Scope and policy
Updated January 2016
The Revista Chilena de Cirugía (Chilean Journal of Surgery) is the official journal of the Sociedad de Cirujanos de Chile (Surgeons Society of Chile) and publishes original and unpublished articles on medical topics, including, in particular, articles on basic and clinical research, review articles, and other documents, giving preference to those related to Surgery and its associated specialties. It also publishes Editorials, Clinical cases, Letters to the Editor, and Imaging and Surgery.
The articles submitted must not be sent to other scientific journals and, if they comply with the formal publishing requirements, they will be submitted for peer review, ideally to two, who are distinguished members of the medical and scientific community, and appointed by the Editorial Board. This evaluation is anonymous, and the authors and peer reviewers are unknown to each other. The evaluation will be performed within a period 30 days. It will include a review of the style, as well of the methodology, with this latter in accordance with the criteria described in Table 1 at the end of this document.
The article may be rejected or accepted in its entirety, and also may be accepted with the modifications or clarifications requested by the reviewers. In the case of controversies, these will be resolved in a further review and/or by the Editor.
The work will then be returned to the author for the suggested corrections, which should be completed within 30 days. Once returned, the Editor will decide if it requires a new review by the evaluators, or if it can be published.
Form and preparation of manuscripts
BEFORE YOU BEGIN
Ethics in publishing
Human and animal rights
If the work involves the use of animal or human subjects, the author should ensure that the work described has been carried out in accordance with:
The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans http://www.wma.net/en/30publications/10policies/b3/index.html; Directiva UE 2010/63/UE for experiments involving humans http://ec.europa.eu/environment/chemicals/lab_animals/legislation_en.htm; Uniform Requirements for manuscripts submitted to Biomedical journals http://www.icmje.org.
Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.
Conflict of interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. If there are no conflicts of interest, then please state this: 'Conflicts of interest: none'.
See also http://www.elsevier.com/conflictsofinterest. Further information and an example of a Conflict of Interest form can be found at: http://help.elsevier.com/app/answers/detail/a_id/286/p/7923.
Submission declaration and verification
Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis or as an electronic preprint, see http://www.elsevier.com/sharingpolicy), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality detection service CrossCheck http://www.elsevier.com/editors/plagdetect.
All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted.
Changes to authorship
This policy concerns the addition, deletion, or rearrangement of author names in the authorship of accepted manuscripts.
Before the accepted manuscript is published in an online issue: Requests to add or remove an author, or to rearrange the author names, must be sent to the Journal Manager from the corresponding author of the accepted manuscript and must include: (a) the reason the name should be added or removed, or the author names rearranged and (b) written confirmation (e-mail, fax, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed. Requests that are not sent by the corresponding author will be forwarded by the Journal Manager to the corresponding author, who must follow the procedure as described above. Note that: (1) Journal Managers will inform the Journal Editors of any such requests and (2) publication of the accepted manuscript in an online issue is suspended until authorship has been agreed.
After the accepted manuscript is published in an online issue: Any requests to add, delete, or rearrange author names in an article published in an online issue will follow the same policies as noted above and result in a corrigendum.
Upon acceptance of an article authors will be asked to complete an ‘Exclusive License Agreement’ (for more information see http://www.elsevier.com/OAauthoragreement and http://www.elsevier.com/copyright).
An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.
This is an open access journal: all articles will be immediately and permanently free for everyone to read and download.
In this agreement the author accepts the transfer of copyright of the article to the Society. The re-use of its contents being defined by the licence of use, CC BY-NC-ND (Creative Commons Attribution-NonCommercial-NoDerivatives License), which allows the article to be read, printed and downloaded, extracted and re-use extracts in other articles, as well as to distribute it in Open Access repositories, and translate it for personal use. This licence does not permit commercial use of the article.
If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases: please consult http://www.elsevier.com/permissions.
As an author you (or your employer or institution) have certain rights to reuse your work. For more information see http://www.elsevier.com/copyright.
Submit your article
Please submit your article via: http://ees.elsevier.com/RCHIC. There you will find all the information needed to make the submission. The use of this resource enables the status of the manuscript to be followed via the indicated web page.
The text of the manuscript (except the first page or title page), with the resumen/abstract, the palabras clave/keywords, the literature references, the Tables and their legends and the figure footnotes should be included in a single file, while each one of the Figures will be submitted in separate files. These documents will be uploaded to the “Attach Files” section.
Specific instructions for each section
The authors should adapt the works submitted, according to their objectives, to the following categories:
The works will present new relevant information based on the statistical description and / or evaluation of an exclusive series from original research. The body of the work must not exceed 2,500 words (excluding from this number, the Title Page (brief but informative), the Abstract, the acknowledgements, the References, Tables and Figures), and must not contain more than 10 Figures.
The composition of the manuscript will be as follows:
a) Abstract: It must be sufficiently clear and informative to enable the work to be understood without reading the entire article. With a maximum of 250 words, it must be structured and be divided into 5 parts: Objective/ Purpose; Materials and Methods; Results; Discussion, and Conclusion.
It is necessary to provide 3 to 5 key words, and they must not use abbreviations or quote literature references. This information should be based on: www.nlm.nih.gov/mesh/meshhome.html.
In all cases, a resumen in Spanish must be prepared with a similar length and identical parts to the English version. If the Editors consider it necessary, they will request and independent translation.
b) Introduction: It consists of three parts. The first defines the problem; the second makes a brief review of what is known about the problem, and the third part presents the aims of the work, taking into account that set out in the previous paragraphs.
c) Materials and Methods: Describe the selection of the subjects studied: patients or experimental animals, organs, tissues, cells, etc., and their respective controls. Identify the methods, instruments or equipment and procedures employed, with sufficient detail in order to allow other observers to reproduce the results. If well established and frequently used methods are employed (including statistical methods), it will be sufficient to name them and quote the corresponding references. When the methods have been published but are not well-known, provide the references and add a brief description. If the methods are new or apply modifications to existing methods, describe them in detail, justify their use and mention their limitations. When experiments are carried out on humans, explain whether the procedures respect the ethical guidelines in accordance with the Helsinki Declaration (updated in 2000), and that they were reviewed and approved by an ad hoc committee of the institution where the study was carried out; when so required by the Editors, the authors should attach the respective approval document. Identify the drugs and chemical compounds employed, with their generic name, their dose, and administration routes. Identify the patients using consecutive numbers, but do not use their initials or their hospital medical records number. Always indicate the number of patients or observations, the statistical methods employed, and the previously chosen significance level to judge the results. In prospective studies, it must mention that it was conducted with the informed consent.
d) Results and Discussion: The composition of groups, age, sex, and clinical signs of the patients must be clearly established. All the results as regards the work are presented in a clear and logical manner (including the P values and confidence intervals, where applicable), also including the negative results. If Tables are used, these and the text must not repeat the information. The past tense will be used. The illustrations relevant to the cases /series analysed / studied must be included in this section.
The materials and methods will be discussed, and the validity of the results examined. In the first paragraph, the authors must expound on the response to the question approached, and the purpose of the work. This then enables the results to be placed in relation to previous knowledge, and compare them with the existing literature. The performances, limits, false diagnoses, etc., must be discussed in this section, as well as the solutions to the problem approached.
Present your results by following a logical and concordant sequence in the text, Tables and Figures. The data may be shown in the Tables or Figures, but not simultaneously in both. In the text, highlight the important observations, without repeating all the data presented in the Tables or Figures. Do not mix the presentation of the results with the discussion.
e) Conclusion: The results of the study and their consequences will be briefly summarised. These must strictly emerge from the cases analysed.
f) Literature References or Bibliography: There can be no more than 40 literature references. (Consult the Literature References section).
Update of a topic or technique of the specialty, as well as any modification of diagnostic algorithms that may lead to the appearance of new techniques. It is an article based on the description of the experience of the author on a specific topic, based on a solid literature review. Also included in this category are works on associated topics (legislation, professional practice, etc.)
The Abstract must not be structured and may not exceed 250 words. The aim and the essential parts are established. An abstract in English and Spanish (resumen) must be provided with up to 5 key words/palabras clave.
The body of the work must not exceed 3,000 words. There should be no more than 40 literature references and only up to 10 Figures or Tables will be included.
In this section the article reflects the experience lived through by the author, and the reflections on a medical topic or associated with professional practice or medical training. The author must be recognised nationally or internationally. It will have a maximum length of 2,500 words, and unstructured abstract /resumen of up to 250 words.
Clinical Cases / Case Series
For this section, consideration will be given to case-series studies that make a substantial contribution to medical knowledge. The text should contain a maximum of 1,700 words, not including the Figure legends or bibliography. There must be no more than 15 literature references. There can be no more than a total of 4 Tables and Figures. The Abstract / Resumen will have a maximum of 180 words, and must be structured, and 3 key words / palabras clave will be provided. Up to a maximum of 4 authors will be accepted.
Letters to the Editor
The body of the work must not exceed 1,000 words.
Imaging and Surgery
The text can have up to 200 words, accompanied by up to 4 images.
The references must be written double-spaced, beginning on a separate page, and must be numbered consecutively according to the order that they appear in the text, and in Vancouver format. All the references that are listed in the bibliography must, without fail, be included as a reference in the text. These references should be written in superscript (for example21) and will appear at the end of the text that contains the referenced information. When citing the names of authors, the reference must be included immediately after it (for example, Greenway G. et al.4). The references must be numbered consecutively, in the same order in which they appear for the first time in the text.
In references where there are six or less authors, all of them must be included with surname and initial of name. If there are seven or more authors, only the first six should be identified and then must be followed by et al.
The title of the journals should be abbreviated in accordance Indicus Medicus MEDLINE (available at: http://www.ncbi.nlm.nih.gov/pubmed).
They must be accompanied by a short descriptive title and be numbered in the order that they appear in the text. They must be self-explanatory and not duplicate data supplied in the text or Figures. The literature references must be numbered in sequence with those of the text. The abbreviations must be clarified in a footnote.
If data from another, published or unpublished source are used, written approval in writing must be requested from the journal or the publisher and acknowledge their origin.
Figures or Illustrations
Any illustration that is not a Table is defined as a Figure (e.g.: graphs, radiographs, electrocardiograms, ultrasound scans, etc.). They must be limited to those that show findings essentially described in the text. Up to a maximum of 10 images will be accepted for Originals and Reviews, and up to 6 for Clinical Cases. The number of the Figure must coincide with the number assigned in the text, and is assigned consecutively.
They must be of excellent resolution, and uniform in size and magnification. The formats employed must be JPG or TIFF and 300 dots per inch (dpi). If the Figures have been electronically manipulated, it is recommended to identify them and clarify the type of modification made, accompanying them with an original image (pre-processed).
The illustrations of histology slices should be accompanied by notes that indicate the stain and magnification used, as well as the relevant histological findings.
The areas of interest in the Figure must be pointed out with clearly visible signs (arrow, arrowhead, asterisk, circles, etc.), carried out in the Photoshop application.
The images must not contain data that may enable the patients, the authors, or the institution to which they belong, to be identified. Neither should they contain letters or numbers. The identification must be in the name of the file. All these must be numbered according to their order of appearance and with their corresponding letters (for example; 1a, 1b, 1c, etc.).
Each Figure must be accompanied by its respective notes. All notes must be written on the same page of the manuscript, double-spaced, like the rest of the text. In the notes, it is recommended to include, according to the case, age, sex, and diagnosis.
If there are literature references in the Figure legends, they must be numbered in sequence with those of the text. If symbols, arrows, numbers or letters are used to identify different parts of the Figures, they must be identified and each one explained in the foot note.
Only acknowledge those individuals or institutions that have made substantial contributions to your work.
Use of the Digital Object Identifier
The Digital Object Identifier (DOI) may be used to cite and link to electronic documents. The DOI consists of a unique alpha-numeric character string which is assigned to a document by the publisher upon the initial electronic publication. The assigned DOI never changes. Therefore, it is an ideal medium for citing a document, particularly 'Articles in press' because they have not yet received their full bibliographic information.
When you use a DOI to create links to documents on the web, the DOIs are guaranteed never to change.
One set of page proofs (as PDF files) will be sent by e-mail to the corresponding author. If you do not wish to use the PDF annotations function, you may list the corrections (including replies to the Query Form) and return them to Elsevier in an e-mail.
Please use this proof only for checking the typesetting, editing, completeness and correctness of the text, tables and figures. Significant changes to the article as accepted for publication will only be considered at this stage with permission from the Editor. We will do everything possible to get your article published quickly and accurately. It is important to ensure that all corrections are sent back to us in one communication: please check carefully before replying.
You can track your accepted article at: www.elsevier.com/trackarticle. You are also welcome to contact Customer Support via http://support.elsevier.com.
Submission of manuscripts
Paper should be sent directly to:
[About the journal] [Editorial board] [Subscription]
Sociedad de Cirujanos de Chile
Román Díaz #205, Of. 401
Santiago - Chile
Tel.: (56-2) 2236 2831
Fax: (56-2) 2236 6759